148 related articles for article (PubMed ID: 25250205)
1. In vivo phage display selection of an ovarian cancer targeting peptide for SPECT/CT imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Am J Nucl Med Mol Imaging; 2014; 4(6):561-70. PubMed ID: 25250205
[TBL] [Abstract][Full Text] [Related]
2. In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas.
Deutscher SL; Figueroa SD; Kumar SR
J Labelled Comp Radiopharm; 2009 Dec; 52(14):583-590. PubMed ID: 20976123
[TBL] [Abstract][Full Text] [Related]
3. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
Kumar SR; Deutscher SL
J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
[TBL] [Abstract][Full Text] [Related]
4. In vitro high throughput phage display selection of ovarian cancer avid phage clones for near-infrared optical imaging.
Soendergaard M; Newton-Northup JR; Deutscher SL
Comb Chem High Throughput Screen; 2014; 17(10):859-67. PubMed ID: 25360673
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging.
Asar M; Newton-Northup J; Deutscher S; Soendergaard M
Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31717613
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma.
Deutscher SL; Figueroa SD; Kumar SR
Nucl Med Biol; 2009 Feb; 36(2):137-46. PubMed ID: 19217525
[TBL] [Abstract][Full Text] [Related]
7. Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer.
Larimer BM; Deutscher SL
Am J Nucl Med Mol Imaging; 2014; 4(5):435-47. PubMed ID: 25143862
[TBL] [Abstract][Full Text] [Related]
8. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
Larimer BM; Thomas WD; Smith GP; Deutscher SL
Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.
Kumar SR; Quinn TP; Deutscher SL
Clin Cancer Res; 2007 Oct; 13(20):6070-9. PubMed ID: 17947470
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Peptide from
Larimer BM; Deutscher SL
J Mol Biomark Diagn; 2014 May; 5(3):. PubMed ID: 26045973
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X
Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213
[TBL] [Abstract][Full Text] [Related]
12. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional phage-based pretargeted imaging of human prostate carcinoma.
Newton-Northup JR; Figueroa SD; Quinn TP; Deutscher SL
Nucl Med Biol; 2009 Oct; 36(7):789-800. PubMed ID: 19720291
[TBL] [Abstract][Full Text] [Related]
14. Streamlined in vivo selection and screening of human prostate carcinoma avid phage particles for development of peptide based in vivo tumor imaging agents.
Newton-Northup JR; Figueroa SD; Deutscher SL
Comb Chem High Throughput Screen; 2011 Jan; 14(1):9-21. PubMed ID: 20958260
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
[TBL] [Abstract][Full Text] [Related]
16. Melanoma imaging with pretargeted bivalent bacteriophage.
Newton JR; Miao Y; Deutscher SL; Quinn TP
J Nucl Med; 2007 Mar; 48(3):429-36. PubMed ID: 17332621
[TBL] [Abstract][Full Text] [Related]
17. Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.
Newton-Northup J; Deutscher SL
Methods Mol Biol; 2017; 1572():445-465. PubMed ID: 28299705
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.
Guo H; Lu J; Hathaway H; Royce ME; Prossnitz ER; Miao Y
Bioconjug Chem; 2011 Aug; 22(8):1682-9. PubMed ID: 21749045
[TBL] [Abstract][Full Text] [Related]
19. Identification of a high affinity TAG-72 binding peptide by phage display selection.
Xiao N; Cheng D; Wang Y; Chen L; Liu X; Dou S; Liu G; Liang M; Hnatowich DJ; Rusckowski M
Cancer Biol Ther; 2011 Jan; 11(1):22-31. PubMed ID: 20980835
[TBL] [Abstract][Full Text] [Related]
20. (68)Ga-labeled phage-display selected peptides as tracers for positron emission tomography imaging of Staphylococcus aureus biofilm-associated infections: Selection, radiolabelling and preliminary biological evaluation.
Nielsen KM; Kyneb MH; Alstrup AK; Jensen JJ; Bender D; Schønheyder HC; Afzelius P; Nielsen OL; Jensen SB
Nucl Med Biol; 2016 Oct; 43(10):593-605. PubMed ID: 27474962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
